First Pharmaceutical Drug To Improve Survival Amongst Patients With Advanced Hepatocarcinoma
Sunday, June 29, 2008 - 16:28
in Health & Medicine
New research has shown that Sorafenib, an orally administered pharmaceutical medicine, results in patients with primary hepatocarcinomas to live 40 percent more on average compared to those not taking the drug.